Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats

Journal of Neural Transmission

Volumn 120, Issue 9, 2013, Pages 1359-1367

  Wamser, Morgahna Nathalie ^a   Leite, Eduardo Fernandes ^a   Ferreira, Vinícius Vialle ^a   Delwing De Lima, Daniela ^b   Da Cruz, José Geraldo Pereira ^a   Wyse, Angela T S ^c   Delwing Dal Magro, Débora ^a  

^a REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

^b UNIVERSITY OF JOINVILLE REGION   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Allopurinol; Ascorbic acid; Butyrylcholinesterase; Hypoxanthine; Lesch Nyhan disease; Trolox

Indexed keywords

ACETYLCHOLINESTERASE; ALLOPURINOL; ASCORBIC ACID; CHOLINESTERASE; FREE RADICAL; HYPOXANTHINE; TROLOX C; URIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; IN VITRO STUDY; LESCH NYHAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ALLOPURINOL; ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BUTYRYLCHOLINESTERASE; CHOLINESTERASES; ENZYME INHIBITORS; FREE RADICALS; HYPOXANTHINE; LESCH-NYHAN SYNDROME; RATS; RATS, WISTAR; URIC ACID;

EID: 84883453677     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-0989-x     Document Type: Article

References (51)

1. Bajgar J (2004) Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151-216
2. Bavaresco CS, Chiarani F, Matte C, Wajner M, Netto CA, Wyse ATS (2005) Effect of hypoxanthine on Na+, K+-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res 1041:198-204
3. Bavaresco CS, Chiarani F, Duringon E, Ferro MM, Cunha CD, Netto CA, Wyse ATS (2007a) Intrastriatal injection of hypoxanthine reduces striatal serotonin content and impairs spatial memory performance in rats. Metab Brain Dis 22:67-76
4. Bavaresco CS, Chiarani F, Wannmacher CM, Netto CA, Wyse ATS (2007b) Intrastriatal hypoxanthine reduces Na(+), K (+)-ATPase activity and induces oxidative stress in the rats. Metab Brain Dis 22:1-11
5. Bavaresco CS, Chiarani F, Kolling J, Ramos DB, Cognato GP, Bonan CD, Bogo MR, Sarkis JJ, Netto CA, Wyse AT (2008) Intrastriatal injection of hypoxanthine alters striatal ectonucleotidase activities: a time-dependent effect. Brain Res 1239:198-206
6. Benzi G, Moretti A (1998) Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? Eur J Pharmacol 346:1-13
7. Bradford MM (1976) A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
8. Burton GW, Wronska U, Stone L, Foster DO, Ingold KU (1990) Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25:199-210
9. Darvesh S, Hopkins D, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurobiol 4:131-138
10. Delwing D, Chiarani F, Delwing D, Bavaresco CS, Wannmacher CMD, Wajner M, Wyse ATS (2003) Proline reduces acetylcholinesterase activity in cerebral cortex of rats. Metab Brain Dis 18:79-86
11. Dubois B, Pillon B (1995) Do cognitive changes of Parkinsons disease result from dopamine depletion? J Neural Transm 45:27-34
12. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
13. Fujimori S (1996) PRPP synthetase superactivity. Nihon Rinsho 54:3309-3314
14. Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CP, Francis PT, Lasheras B, Ramirez MJ (2005) Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43:442-449
15. Geula C, Darvesh S (2004) Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. Drugs Today 40:711-721
16. Geula C, Mesulam MM, Kuo CC, Tokuno H (1995) Postnatal development of cortical acetylcholinesterase-rich neurons in the rat brain: permanent and transient patterns. Exp Neurol 134:157-178
17. Hagan JJ, Alpert JE, Morris RG, Iversen SD (1983) The effects of central catecholamine depletions on spatial learning in rats. Behav Brain Res 9:83-104
18. Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine. Oxford University Press, London
19. Harkness RA, McCreanor GM, Watts RW (1988) Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and in urine with metabolite profiles in CSF. J Inher Metab Dis 11:239-252
20. Henderson JF (1968) Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome. Fed Proc 27:1075-1077
21. Henderson VW, Watt L, Buckwalter JG (1996) Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 21:421-430
22. Hong YS, Lee MJ, Kim KH, Lee SH, Lee YH, Kim BG, Jeong B, Yoon HR, Nishio H, Kim JY (2004) The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J Korean Med Sci 19:209-213
23. Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW (1981) Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 25:67-82
24. Jinnah HA, Friedmann T (2001) Lesch Nyhan disease and it variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2537-2569
25. Klein AS, Joh JW, Rangan U, Wang D, Bulkley GB (1996) Allopurinol: discrimination of antioxidant from enzyme inhibitory activities. Free radical. Biol Med 21:713-717
26. Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36:561-570
27. Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 305:1106-1111
28. Loewi O (1921) Uberhumerole ubertragbarkeit der herznervenwirkung. I Mitteilung Pflugers Arch 189:239-242
29. Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41:31-91
30. Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45:117-127
31. Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyse acetylcholine. Neuroscience 170:627-639
32. Mura A, Feldon J (2003) Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov Disord 18:860-871
33. Myhrer T (2000) Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Rev 41:268-287
34. Nyhan WL (2005) Inherited hyperuricemic disorders. Contrib Nephrol 147:22-34
35. Nyhan WL, Oliver WJ, Lesch M (1965) A familial disorder or uric acid metabolism and central nervous system function II. J Pediatr 67:439-444
36. O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG (2003) Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 13:231-239
37. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308
38. Puig JG, Mateos FA (1993) The biochemical basis of HGPRT deficiency. In: Gresser U (ed) Molecular genetics, biochemistry and clinical aspects of inherited disorders of purine and pyrimidine metabolism. Springer, New York, pp 12-26
39. Rijksen G, Staal GEJ, Van der Vlist MJM, Beerner FA, Troost J, Gutensohn W, Van Laarhoven JPRM, De Bruyn CHMM (1981) Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet 57:39-47
40. Rosenbloom RM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE (1967) Inherited disorder of purine metabolism. JAMA 202:175-177
41. Saito Y, Takashima S (2000) Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev 22:S122-S131
42. Silva CG, Bueno ARF, Schuck PF, Leipnitz G, Ribeiro CA, Rosa RB, Dutra Filho CS, Wyse AT, Wannmacher CM, Wajner M (2004) Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neuchem Int 44:45-52
43. Silver A (1974) The biology of cholinesterases. North-Holland, Amsterdam
44. Srivastava T, O'Neill JP, Dasouki M, Simckes AM (2002) Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. Am J Med Gene 108:219-222
45. Stefanello FM, Monteiro SC, Matté C, Scherer EBS, Netto CS, Wyse ATS (2007) Hypermethioninemia increases cerebral acetylcholinesterase activity and impairs memory in rats. Neurochem Res 32:1868-1874
46. Torres RJ, Puig JG (2007) Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis 8:48
47. Tsakiris S, Angelogianni P, Schulpis KH, Stavridis JC (2000) Protective effect of l-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem 33:103-106
48. Wessler I, Kirkpatrick CJ (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558-1571
49. Wyse ATS, Zugno AI, Streck EL, Matte C, Calcagnotto T, Wannmacher CMD, Wajner M (2002) Inhibition of Na+, K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685-1689
50. Wyse ATS, Stefanello FM, Chiarani F, Delwing D, Wannmacher CMD, Wajner M (2004) Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction. Neurochem Res 29:385-389
51. Yamamoto T, Moriwaki Y, Takahashi S (2005) Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta 356:35-57